Mariner’s Tourmaline Bio TRML Stock Holding History

Mariner’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,579	Closed	-$267K	–	3811
2025 Q3	$267K	Buy	+5,579	New	+$155K	﹤0.01%	2918

Mariner's TRML Position: Q4 2025 in Review

Mariner sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 5,579 shares — an estimated $267K sold.

Mariner first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $267K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Mariner reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Mariner sold 5,579 Tourmaline Bio shares in Q4 2025, an estimated $267K.
Mariner first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Mariner's Tourmaline Bio position peaked at $267K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Mariner's 13F filing for Q4 2025, filed 13 Feb 2026.